-
Over 35 lakh people have received COVID-19 vaccines so far: Health ministry
expresspharma
February 01, 2021
Of the 35,00,027 beneficiaries, the highest number of 4,63,793 people were vaccinated in Uttar Pradesh, followed by 3,24,973 in Rajasthan, 3,07,891 in Karnataka and 2,61,320 in Maharashtra.
-
Mexico to buy AstraZeneca vaccine from India: President Andres Manuel Lopez Obrador
expresspharma
February 01, 2021
Mexico also has a deal with AstraZeneca to produce its vaccine for distribution in Latin America, with financial support from the foundation of Mexican billionaire Carlos Slim.
-
Valneva Begins COVID Vax Production to Optimize Potential Deliveries
contractpharma
January 29, 2021
Valneva SE began production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in an effort to optimize the timeline for potential deliveries of the vaccine.
-
Novartis in discussions to help produce COVID-19 vaccines, tests
expresspharma
January 29, 2021
Novartis last year agreed to license two of Molecular Partners’ antiviral drugs that it hopes to use to treat COVID-19 patients.
-
More COVID-19 vaccines will be introduced in India: Health Minister
expresspharma
January 28, 2021
The health minister said the pandemic has also resulted in heightened nationalism, but it has also shown us how important global cooperation is for everyone.
-
Supplied COVID-19 vaccines to nine countries, will gradually send to COVAX facility: India at UN
expresspharma
January 27, 2021
We are fulfilling our commitment to make our vaccine production and delivery capacity available for the benefit of the entire humanity, said K Nagaraj Naidu, India’s Deputy Permanent Representative to the UN Ambassador.
-
Sanofi to produce 100 million Pfizer/BioNTech vaccine doses: CEO
expresspharma
January 27, 2021
Sanofi will produce more than 100 million doses of the COVID-19 vaccine developed by its competitors Pfizer and BioNTech by the end of the year, said Paul Hudson, CEO of Sanofi in an interview with Le Figaro newspaper.
-
BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong, S.A.R., China for COVID-19 Vaccine
prnewswire
January 26, 2021
BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that according to the Food and Health Bureau of the Hong Kong, S.A.R., China Special Administrative Region of the PRC, the COVID-19 vaccine COMIRNATY® (also known as BNT162b2, Chine
-
Tata in discussion with Moderna to bring its COVID-19 vaccine to India: Reports
expresspharma
January 26, 2021
Data released in November from Moderna’s late-stage study showed it was 94.1 per cent effective with no serious safety concerns.
-
Pfizer, BioNTech announce agreement with COVAX for advance purchase of COVID-19 vaccine
expresspharma
January 25, 2021
Pfizer and BioNTech announced an advance purchase agreement with COVAX for up to 40 million doses of the Pfizer-BioNTech COVID-19 vaccine. The doses will be delivered throughout 2021.